NCT00198991 German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) Status COMPLETED Phase PHASE4
NCT00198978 German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE4
NCT00195104 Arsenic Trioxide in Combination With Cytarabine in Patients With High-risk MDS and Poor-prognosis AML Status COMPLETED Phase PHASE1/PHASE2
NCT00195000 Mylotarg and Ara-C in Untreated Patients Above 60 Years With AML and High-Risk MDS Status COMPLETED Phase PHASE2
NCT00187122 Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma Status COMPLETED Phase NA
NCT00180128 AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia Status UNKNOWN Phase PHASE4
NCT00176462 CINJALL: Treatment for Children With Acute Lymphocytic Leukemia Status COMPLETED Phase PHASE2
NCT00151255 All-Trans Retinoic Acid in Combination With Standard Induction and Consolidation Therapy in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Status COMPLETED Phase PHASE3
NCT00151242 Study on All-Trans Retinoic Acid, Induction and Consolidation Therapy, and Pegfilgrastim After Consolidation Therapy in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Status COMPLETED Phase PHASE2/PHASE3
NCT00143975 Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM) Status COMPLETED Phase PHASE2
NCT00137995 R-ICE Versus R-DHAP in Patients Aged 18-65 With Relapse Diffuse Large B-cell Lymphoma Status COMPLETED Phase PHASE3
NCT00136435 A Study in Adults With Untreated Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE2
NCT00133991 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia Status COMPLETED Phase PHASE2
NCT00131053 Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL) Status UNKNOWN Phase PHASE2
NCT00131027 High-Dose Methotrexate (MTX) for Adult Acute Lymphoblastic Leukemia (ALL) Status UNKNOWN Phase PHASE3
NCT00130195 Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL) Status COMPLETED Phase PHASE2
NCT00129168 Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE1/PHASE2
NCT00126191 Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma Status TERMINATED Phase PHASE2
NCT00124644 Combination Chemotherapy and Tipifarnib in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Status TERMINATED Phase PHASE1